Dexamethasone eluting cochlear implant: Histological study in animal model

Area of Science:

• Otolaryngology
• Biomaterials Science
• Pharmacology

Background:

• Cochlear implantation (CI) advances hearing loss management but can cause inflammation and hair cell damage.
• Glucocorticoids are investigated for reducing CI-induced inflammation, focusing on dosage and delivery.
• Dexamethasone delivery via a drug-eluting CI is explored to mitigate inflammatory responses.

Purpose of the Study:

• To evaluate the histological effect of a dexamethasone-eluting CI on inflammatory cell infiltration.
• To assess the efficacy of local dexamethasone delivery in reducing cochlear inflammation post-implantation.

Main Methods:

• Thirty guinea pigs underwent cochleostomy; 12 received a dexamethasone-eluting CI (Group 1).
• Control groups included 12 animals with a non-eluting CI (Group 2) and six with cochleostomy only (Group 3).
• Inflammatory cell infiltration was compared at days 3 and 13.

Main Results:

• Group 1 showed reduced inflammatory indices compared to Group 2.
• Significant reductions in fibrocyte, macrophage, and giant cell infiltration at day 3 were observed.
• Lymphocyte infiltration, macrophage infiltration, and capillary formation were significantly reduced at day 13.

Conclusions:

• Dexamethasone-eluting CIs demonstrated an attenuated inflammatory response.
• This suggests a viable method for local drug delivery within the cochlea.
• Further research into drug-eluting CIs may improve patient outcomes by reducing inflammation.